Walgreens Partners to Expand Colorectal Cancer Screening Access
The initiative gives eligible pharmacy customers a streamlined pathway to request the Cologuard stool DNA test, with no prep or special diet required.
Category: Colorectal
Colorectal
Latest
Colorectal
Latest
Quest Diagnostics to Expand Blood-Based Colorectal Cancer Screening Access
The company is collaborating with Guardant Health to make Guardant's Shield test available through Quest's nationwide network of provider clients and patient service centers.
Colorectal
Latest
Sysmex to Distribute CRC Screening Solutions in Canada
Sysmex America will distribute Sentinel Diagnostics SENTiFIT 270 and 800 analyzers in Canada for colorectal cancer (CRC) screening.
FDA Approves Exact Sciences’ Non-Invasive Test for Colorectal Cancer Screening
The FDA approved Exact Sciences’ Cologuard Plus test, a stool DNA test that enhances colorectal cancer and precancerous lesion detection.
Read More
Colorectal Cancer Screening Getting a Non-Invasive Boost
Stool-based tests are promising alternatives to colonoscopy for colorectal cancer screening, addressing global accessibility challenges.
Read More
Breakthroughs in Diagnosing Colorectal Cancer with Rare Genetic Variants
A new study emphasizes the potential of advanced sequencing techniques in improving outcomes for CRC patients with rare genetic variants.
Read More
Nationwide Survey Shows Gap in Awareness of Colon Cancer RiskÂ
New research highlights a lack of awareness regarding family history of colorectal cancer, putting many at risk of undiagnosed colon cancer.
Read More
Universal DX Initiates Clinical Trial for FDA Approval of Colorectal Cancer Test
Universal DX initiated a clinical trial for its colorectal cancer screening blood test with the goal of achieving FDA premarket approval.
Read More
AI Bowel Cancer Test Can Tell if Patients Need Chemotherapy
A new AI-based test assesses CD3 immune cells in early-stage bowel cancer tumors to predict recurrence risk.
Read More
Hot Spots to Improve Colorectal Cancer Screening in Hispanic/Latino Communities Identified
Researchers have identified geographic “hot spots” in the U.S. with low colorectal cancer screening rates among Hispanic/Latino communities.
Read More
At-Home Colon Cancer Screening Test Reduces Risk of Colorectal Cancer Death
A new study reveals that an at-home colorectal cancer screening test, FIT, can reduce the risk of colorectal cancer death by 33%.
Read More
Mainz Biomed Announces FDA Breakthrough Device Designation Submission for CRC Test
Mainz Biomed has applied for FDA Breakthrough Device Designation for its advanced non-invasive colorectal cancer screening test.
Read More
New Industry Collaboration Seeks to Advance Colorectal Cancer Screening
The new collaboration aims to enhance colorectal cancer (CRC) screening using advanced diagnostic platforms and novel biomarkers.
Read More
Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week
Mainz Biomed unveiled findings of the eAArly DETECT study that demonstrated high sensitivity and specificity of their colorectal cancer test.
Read More
FDA Advisory Committee Panel Recommends Approval of Colorectal Blood Test
The FDA’s Medical Devices Advisory Committee recommended approval of Guardant Health’s Shield blood test for colorectal cancer screening.
Read More
Some Patients Repeat Fecal Tests to Delay Colonoscopy
A new study found that 7.4% of patients repeated fecal testing rather than proceeding directly to colonoscopy as guidelines recommend.
Read More
Choice of Tests Doubled Colorectal Cancer Screening
Offering a choice between colonoscopy and a take-home screening kit more than doubled colorectal cancer screening rates.
Read More
Mainz Biomed Colorectal Cancer Diagnostic Part of FDA Trial
Mainz Biomed N.V. announced results from a clinical study to evaluating integrating its portfolio into its colorectal cancer screening tool.
Read More